Since a role for HIF-2α has been described in chronic hypoxia associated to NASH (18, 19, 28), we hypothesised that HIF-2α may promote YAP activation, increasing energy demand and accelerating fibrosis progression. Here, EPAS1 is linked to metabolic dysfunction-associated steatohepatitis.